Fundraising Fox

New Enterprise Associates (NEA) β€” 2024 Investments

12 investments dated 2024 Β· listed companies and verified rows first Β· show all

Onkure Therapeutics Inconkuretherapeutics.comin𝕏NASDAQ: OKUROct 2024SEC filingmedium confidence

OnKure Therapeutics is a clinical-stage biopharmaceutical company developing PI3KΞ± pan-mutant selective inhibitor medicines for the treatment of breast cancer and vascular anomalies.

BiotechDigital HealthHealthtechMedical DevicesBoulder, US

Jason Leverone(Executive Officer)Samuel Agresta(Executive Officer)Dylan Hartley(Executive Officer)Nicholas Saccomano(Executive Officer, Director)Wendy Johnson(Executive Officer)

BoardIsaac Manke(Director)in

Board seatEdward T. MathersΒ· per SEC Form D Β· $65M raise Β· filed Oct 2024

Co-investorsAccess BiotechnologyRiverVest Venture PartnersAbingworthACORN BIOVENTURESBoulder Ventures

Moximedmoximed.comAug 2024

HealthtechFremont, US

Anton Clifford(Executive Officer)James Leech(Executive Officer)Christopher Gleason(Executive Officer)Kevin K. Sidow(Executive Officer, Director)

BoardShahzad Malik(Director)in

Board seatJoshua MakowerΒ· per SEC Form D

Co-investorsLightstone VenturesRunway Growth CapitalAdvent Life SciencesGBS Venture Partners Ltd.Gilde HealthcareVertex Ventures HC

PayZenpayzen.comin𝕏Sep 2024

PayZen provides AI-powered, interest-free patient financing that lets patients pay medical bills over time through personalized payment plans, with pre-built EHR integrations and automated servicing for providers.

AI & Machine LearningDigital HealthFintechHealthtechSan Francisco, US

Tobias Mezger(Executive Officer, Director)inIsaac Cohen(Executive Officer, Director)Ariel Rosenthal(Co-Founder & CTO)inItzik Cohen(Co-Founder & CEO)inAntonio Martino(Executive Officer)

BoardLee Shapiro(Director)in

Board seatMohamad MakhzoumiΒ· per SEC Form D

Co-investors7wire VenturesSignalFireCorewell Health VenturesHaymaker VenturesLink VenturesLorimer Ventures+3 more

Stable Coin Inc.Jun 2024SEC filingmedium confidence

Des Moines, US

Ben Milne(Executive Officer, Director)Jeff Milewski(Executive Officer, Director)

Board seatAlex SharataΒ· per SEC Form D Β· $2.5M raise Β· filed Jun 2024

Twelve Labstwelvelabs.ioin𝕏Apr 2024

Twelve Labs develops AI technology for video understanding, enabling machines to comprehend and analyze video content for applications in human-machine interaction and perception.

AI & Machine LearningData & InfrastructureMedia & EntertainmentSan Francisco, US

Jae Sung Lee(Executive Officer, Director)Seung Joon Lee(Executive Officer, Director)Jin Woo Chung(Executive Officer, Director)Soyoung Lee(Executive Officer, Director)Aiden L.(Founder)inDong Shin Kim(Director)

Board seatTiffany LuckΒ· per SEC Form D

Co-investorsExpaHan River PartnersHillspring InvestmentHubSpot VenturesIndex VenturesIntel Capital+12 more

AI Squaredsquared.aiinApr 2024 Β· $13.8M

AISquared provides an enterprise platform (UNIFI) to build, deploy, and govern agentic AI workflows across existing business systems, connecting trusted data, orchestration, embedded delivery, security, and analytics.

AI & Machine LearningEnterprise SoftwareSaaSSan Francisco, US

Jacob Renn(Founder)Benjamin Harvey, Ph.D.(Founder)inBenjamin Harvey(Founder)in

Co-investorsAnsa CapitalLatimer Ventures

Brenig Therapeutics, Inc.Jul 2024

BiotechDover, US

Iain Dukes(Executive Officer, Director)Nikolay Savchuk(Executive Officer, Director)

BoardKeno Gutierrez(Director)Edward Mathers(Director)Michele Cucullu(Director)

Co-investorsNEA Secondary

Comanche Biopharmacomanchebiopharma.cominJan 2024 Β· $75M

Comanche Biopharma is a biopharmaceutical company developing an investigational siRNA medicine (CBP-4888) targeting a root cause of preterm preeclampsia in pregnant women.

BiotechFemTechHealthtechConcord, US

Mike Young(Founder)T Scott Johnson(Founder)inPaul Antinori(Executive Officer)Allison August(Executive Officer)Michael Young(Executive Officer)Thomas Scott Johnson(Executive Officer, Director)

Co-investorsAtlas VentureGV (Google Ventures)Broadview VenturesF-Prime CapitalLilly Asia Ventures

Metronomemetronome.comin𝕏Jan 2024 Β· $43M

Metronome provides a usage-based billing platform for SaaS companies, enabling them to launch products faster and make data-driven revenue decisions.

Enterprise SoftwareFintechSaaS

Scott Woody(Founder)inAndrew Garvin(Founder)in

Co-investorsAndreessen HorowitzGeneral CatalystActivant CapitalSINEWAVE VENTURESWorkday Ventures

Rewindrewind.comin𝕏Apr 2024

Rewind provides backup, restore, and copy functionality for critical data across SaaS and cloud applications, serving over 25,000 organizations globally across eCommerce, accounting, productivity, and development use cases.

Cloud ComputingData & InfrastructureEnterprise SoftwareSaaS

Mike Potter(Co-founder & CEO)inJamesin

Co-investorsAtlassian VenturesBessemer Venture PartnersH.I.G. CapitalInovia CapitalInsight PartnersMistral Venture Partners+6 more

Rewindrewind.earthApr 2024

Rewind performs permanent carbon removal by backfilling mine voids with sustainably sourced biomass, which simultaneously fulfills mine reclamation obligations for the mining industry.

Circular EconomyCleantechClimate Tech

Co-investorsMensch Capital PartnersYes VCZORAAndreessen HorowitzFirst Round CapitalH.I.G. Growth Partners+2 more

Sorasoraschools.comin𝕏Feb 2024

Sora Schools provides an engaging, personalized learning experience built by educators, designers, and engineers.

EdTech

Co-investorsContraryHoneystone VenturesUnion Square Ventures (USV)Inspired CapitalPeak State VenturesRethink Capital Partners+3 more

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.